Treatment Research Team, Medical Treatment for High Dose Exposure Research Group, Research Center for Radiation Emergency Medicine, National Institute of Radiological Sciences, 4-9-1 Anagawa, Inage-ku, Chiba, Japan.
J Radiat Res. 2010;51(1):81-6. doi: 10.1269/jrr.09095. Epub 2009 Oct 23.
It is well known that a pre-administration of proinflammatory cytokines alters hematopoietic progenitor cells to promote an increase resistance against radiation and increases the survival rate in mice irradiated with lethal doses of radiation. Inflammation stimulators, such as some bacterial constituents, are also reported to have similar radioprotective action. We found that pre-administration of heat-killed Lactobacillus casei (HLC) to mice increases the level of interleukin (IL)-1 beta in circulation as well as the survival rate following lethal dose of radiation. Since HLC stimulates early immune responses, effects by drugs to modify inflammation were studied. The increase of both blood IL-1 beta levels and survival rates by HLC were simultaneously accelerated by coadministration of mineralocorticoid and inhibited by glucocorticoids or corticotropin. Neither parameter was modified by non-steroidal anti-inflammatory or anti-rheumatoid drugs. This suggests that both expected radioprotective action and unexpected systemic action, realized as an increase in plasma cytokines, by inflammation-related radioprotectors can be controlled by the coadministration of drugs at least in C3H/He mice, based on consideration of their pharmacological properties.
众所周知,预先给予促炎细胞因子会改变造血祖细胞,以促进对致死剂量辐射的辐射抗性增加,并提高受照射小鼠的存活率。炎症刺激物,如某些细菌成分,也被报道具有类似的放射保护作用。我们发现,预先给予热灭活干酪乳杆菌(HLC)可增加循环中白细胞介素(IL)-1β的水平,并提高受致死剂量辐射的小鼠的存活率。由于 HLC 刺激早期免疫反应,因此研究了改变炎症的药物的作用。HLC 同时加速了血液中 IL-1β水平和存活率的增加,这一过程可被盐皮质激素共同给药加速,而被糖皮质激素或促皮质素抑制。非甾体类抗炎药或抗风湿药均未改变这两个参数。这表明,基于对其药理学特性的考虑,炎症相关放射保护剂的预期放射保护作用和作为血浆细胞因子增加的意外全身作用可以通过药物共同给药来控制,至少在 C3H/He 小鼠中是如此。